N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide

C22H26N4O4 — CID 124842257

IUPACN-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide
SMILESCc1cc(C)n(C[C@@H]2CCCO2)c(=O)c1C(=O)Nc1ccc2c(c1)nc(CO)n2C
InChIInChI=1S/C22H26N4O4/c1-13-9-14(2)26(11-16-5-4-8-30-16)22(29)20(13)21(28)23-15-6-7-18-17(10-15)24-19(12-27)25(18)3/h6-7,9-10,16,27H,4-5,8,11-12H2,1-3H3,(H,23,28)/t16-/m0/s1
InChIKeyBXVFCPBXVKIISP-INIZCTEOSA-N
MW410.47 g/mol
LogP2.28
Rot. Bonds5

About N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide

N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide (PubChem CID 124842257) has the molecular formula C22H26N4O4 and a molecular weight of 410.47 g/mol. Its IUPAC name is N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide.

Molecular Properties

Compound NameN-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide
PubChem CID124842257
Molecular FormulaC22H26N4O4
Molecular Weight410.47 g/mol
Exact Mass410.20
IUPAC NameN-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide
SMILESCc1cc(C)n(C[C@@H]2CCCO2)c(=O)c1C(=O)Nc1ccc2c(c1)nc(CO)n2C
InChIInChI=1S/C22H26N4O4/c1-13-9-14(2)26(11-16-5-4-8-30-16)22(29)20(13)21(28)23-15-6-7-18-17(10-15)24-19(12-27)25(18)3/h6-7,9-10,16,27H,4-5,8,11-12H2,1-3H3,(H,23,28)/t16-/m0/s1
InChIKeyBXVFCPBXVKIISP-INIZCTEOSA-N
XLogP2.28
TPSA98.38 Ų
H-Bond Donors2
H-Bond Acceptors7
Rotatable Bonds5
Heavy Atoms30
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500410.47
LogP ≤ 52.28
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 107

Analyze N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide?
The IUPAC name of N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide (CID 124842257) is N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide.
What is the SMILES notation for N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide?
The canonical SMILES for N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide is Cc1cc(C)n(C[C@@H]2CCCO2)c(=O)c1C(=O)Nc1ccc2c(c1)nc(CO)n2C.
What is the InChIKey of N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide?
The InChIKey is BXVFCPBXVKIISP-INIZCTEOSA-N. The full InChI is InChI=1S/C22H26N4O4/c1-13-9-14(2)26(11-16-5-4-8-30-16)22(29)20(13)21(28)23-15-6-7-18-17(10-15)24-19(12-27)25(18)3/h6-7,9-10,16,27H,4-5,8,11-12H2,1-3H3,(H,23,28)/t16-/m0/s1.
What are the key properties of N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide?
N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide has a molecular weight of 410.47 g/mol, XLogP of 2.28, 5 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-(hydroxymethyl)-1-methylbenzimidazol-5-yl]-4,6-dimethyl-2-oxo-1-[[(2S)-oxolan-2-yl]methyl]pyridine-3-carboxamide is sourced from PubChem (CID 124842257), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).